Literature DB >> 25697826

Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS.

L Comley1, I Allodi1, S Nichterwitz1, M Nizzardo2, C Simone2, S Corti2, E Hedlund3.   

Abstract

The lethal disease amyotrophic lateral sclerosis (ALS) is characterized by the loss of somatic motor neurons. However, not all motor neurons are equally vulnerable to disease; certain groups are spared, including those in the oculomotor nucleus controlling eye movement. The reasons for this differential vulnerability remain unknown. Here we have identified a protein signature for resistant oculomotor motor neurons and vulnerable hypoglossal and spinal motor neurons in mouse and man and in health and ALS with the aim of understanding motor neuron resistance. Several proteins with implications for motor neuron resistance, including GABAA receptor α1, guanylate cyclase soluble subunit alpha-3 and parvalbumin were persistently expressed in oculomotor neurons in man and mouse. Vulnerable motor neurons displayed higher protein levels of dynein, peripherin and GABAA receptor α2, which play roles in retrograde transport and excitability, respectively. These were dynamically regulated during disease and thus could place motor neurons at an increased risk. From our analysis is it evident that oculomotor motor neurons have a distinct protein signature compared to vulnerable motor neurons in brain stem and spinal cord, which could in part explain their resistance to degeneration in ALS. Our comparison of human and mouse shows the relative conservation of signals across species and infers that transgenic SOD1G93A mice could be used to predict mechanisms of neuronal vulnerability in man.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  amyotrophic lateral sclerosis; motor neuron; neurodegeneration; oculomotor; selective vulnerability

Mesh:

Year:  2015        PMID: 25697826     DOI: 10.1016/j.neuroscience.2015.02.013

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

Review 2.  New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.

Authors:  Danielle Arbour; Christine Vande Velde; Richard Robitaille
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

3.  Supersaturated proteins in ALS.

Authors:  Elliott Hayden; Alan Cone; Shulin Ju
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-09       Impact factor: 11.205

4.  Motor neuron degeneration following glycine-mediated excitotoxicity induces spastic paralysis after spinal cord ischemia/reperfusion injury in rabbit.

Authors:  Li Wang; Sen Li; Yuan Liu; Dong-Liang Feng; Long Jiang; Zai-Yun Long; Ya-Min Wu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Circuit-Specific Early Impairment of Proprioceptive Sensory Neurons in the SOD1G93A Mouse Model for ALS.

Authors:  Soju Seki; Toru Yamamoto; Kiara Quinn; Igor Spigelman; Antonios Pantazis; Riccardo Olcese; Martina Wiedau-Pazos; Scott H Chandler; Sharmila Venugopal
Journal:  J Neurosci       Date:  2019-09-17       Impact factor: 6.167

6.  Novel combinatorial screening identifies neurotrophic factors for selective classes of motor neurons.

Authors:  Sébastien Schaller; Dorothée Buttigieg; Alysson Alory; Arnaud Jacquier; Marc Barad; Mark Merchant; David Gentien; Pierre de la Grange; Georg Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

7.  Arginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons.

Authors:  Zoltan Simandi; Krisztian Pajer; Katalin Karolyi; Tatiana Sieler; Lu-Lin Jiang; Zsuzsanna Kolostyak; Zsanett Sari; Zoltan Fekecs; Attila Pap; Andreas Patsalos; Gerardo Alvarado Contreras; Balint Reho; Zoltan Papp; Xiufang Guo; Attila Horvath; Greta Kiss; Zsolt Keresztessy; György Vámosi; James Hickman; Huaxi Xu; Dorothee Dormann; Tibor Hortobagyi; Miklos Antal; Antal Nógrádi; Laszlo Nagy
Journal:  J Neurosci       Date:  2018-07-27       Impact factor: 6.167

Review 8.  TDP-43 and Cytoskeletal Proteins in ALS.

Authors:  Moritz Oberstadt; Joseph Claßen; Thomas Arendt; Max Holzer
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

Review 9.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

10.  Respiratory pathology in the Optn-/- mouse model of Amyotrophic Lateral Sclerosis.

Authors:  Angela L McCall; Justin S Dhindsa; Logan A Pucci; Amanda F Kahn; Anna F Fusco; Debolina D Biswas; Laura M Strickland; Henry C Tseng; Mai K ElMallah
Journal:  Respir Physiol Neurobiol       Date:  2020-08-14       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.